Phase II trial of fenretinide (NSC 374551) in patients with recurrent small cell lung cancer

Author:

Schneider Bryan J.,Worden Francis P.,Gadgeel Shirish M.,Parchment Ralph E.,Hodges Collette M.,Zwiebel James,Dunn Rodney L.,Wozniak Antoinette J.,Kraut Michael J.,Kalemkerian Gregory P.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Oncology

Reference37 articles.

1. Jemal A, Murray T, Siegel R et al (2008) Cancer statistics, 2008. CA Cancer J Clin 58:71–96 doi: 10.3322/CA.2007.0010

2. Murray N, Erridge S, Turrisi AT (2005) Multimodality therapy for limited stage small cell lung cancer: combination chemotherapy and thoracic irradiation. In: Pass HI, Carbone DP, Johnson DH, Minna JD, Turrisi AT (eds) Lung cancer: principles and practice. Lippincott Williams & Wilkins, Philadelphia, pp 674–691

3. Spira A, Ettinger DS (2004) Multidisciplinary management of lung cancer. N Engl J Med 350:379–392 doi: 10.1056/NEJMra035536

4. Chute JP, Chen T, Feigal E et al (1999) Twenty years of phase III trial for patients with extensive-stage small cell lung cancer: perceptible progress. J Clin Oncol 17:1794–1801

5. Schneider BJ (2008) Management of recurrent small cell lung cancer. JNCCN 6:323–331

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3